Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
50 enrolled
inMMyCAR
Phase 1 Recruiting
40 enrolled
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Phase 1 Recruiting
364 enrolled
DXP-106
Phase 1 Recruiting
54 enrolled
A Study of ASP3082 in Adults With Advanced Solid Tumors
Phase 1 Recruiting
681 enrolled
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Phase 1 Recruiting
220 enrolled
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Phase 1 Recruiting
127 enrolled
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 Recruiting
24 enrolled
A Study of JNJ-87890387 for Advanced Solid Tumors
Phase 1 Recruiting
200 enrolled
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Phase 1 Recruiting
383 enrolled
Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
Phase 1 Recruiting
500 enrolled
An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors
Phase 1 Recruiting
50 enrolled
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Phase 1 Recruiting
250 enrolled
A Study of ZW191 in Participants With Solid Tumors
Phase 1 Recruiting
145 enrolled
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
Phase 1 Recruiting
65 enrolled
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Phase 1 Recruiting
234 enrolled
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Phase 1 Recruiting
386 enrolled
A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha
Phase 1 Recruiting
45 enrolled
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Phase 1 Recruiting
154 enrolled
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
Phase 1 Recruiting
97 enrolled
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Phase 1 Recruiting
42 enrolled
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
Phase 1 Recruiting
55 enrolled
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Phase 1 Recruiting
188 enrolled
Application of ā¶āøGa-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.
Phase 1 Recruiting
30 enrolled
MTAPESTRY 103
Phase 1 Recruiting
350 enrolled
A Study of PHN-012 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
165 enrolled
PNOC028
Phase 1 Recruiting
24 enrolled
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Phase 1 Recruiting
345 enrolled
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Phase 1 Recruiting
124 enrolled
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Phase 1 Recruiting
70 enrolled
STRIKE-001
Phase 1 Recruiting
144 enrolled
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
132 enrolled
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
Phase 1 Recruiting
41 enrolled
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
Phase 1 Recruiting
276 enrolled
Study of CHS-114 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
87 enrolled
KEYNOTE-E12
Phase 1 Recruiting
78 enrolled
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Phase 1 Recruiting
134 enrolled
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Phase 1 Recruiting
210 enrolled
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
290 enrolled
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies
Phase 1 Recruiting
42 enrolled
MK-8294-001
Phase 1 Recruiting
67 enrolled
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Phase 1 Recruiting
110 enrolled
Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer
Phase 1 Recruiting
40 enrolled
AZD5305
Phase 1 Recruiting
8 enrolled
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
Phase 1 Recruiting
150 enrolled
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Phase 1 Recruiting
250 enrolled
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Phase 1 Recruiting
140 enrolled
A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy Participants
Phase 1 Recruiting
104 enrolled
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Phase 1 Recruiting
80 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled